Needleless Systems for Intravenous Therapy: Implications for Australian Infection Control

Research output: Contribution to journalArticleResearchpeer-review

Abstract

Infection Control Practitioners (ICP) are often responsible for recommending the piloting or introduction of new devices in clinical settings. The obligation of employers to provide staff and patients with equipment which minimises their risk of acquiring either occupational or nosocomial infection has lead to an increase in the number of safety devices available. Infection Control practitioners must be prudent in their judgement of both the merits and potential complications of introducing new equipment. This paper reviews existing literature on needleless devices and illustrates the need for ICP to be competent in assessing and undertaking research on new devices and the issues to be considered by ICP in their product evaluation.
Original languageEnglish
Pages (from-to)12-17
Number of pages6
JournalHealthcare Infection
Volume1
Issue number8
DOIs
Publication statusPublished - 1995

Fingerprint

Infection Control Practitioners
Infection Control
Equipment and Supplies
Protective Devices
Therapeutics
Cross Infection
Research

Cite this

@article{9fc263bf29cb4abaa4e2ac891f234ad6,
title = "Needleless Systems for Intravenous Therapy: Implications for Australian Infection Control",
abstract = "Infection Control Practitioners (ICP) are often responsible for recommending the piloting or introduction of new devices in clinical settings. The obligation of employers to provide staff and patients with equipment which minimises their risk of acquiring either occupational or nosocomial infection has lead to an increase in the number of safety devices available. Infection Control practitioners must be prudent in their judgement of both the merits and potential complications of introducing new equipment. This paper reviews existing literature on needleless devices and illustrates the need for ICP to be competent in assessing and undertaking research on new devices and the issues to be considered by ICP in their product evaluation.",
author = "Cathryn Murphy",
year = "1995",
doi = "10.1016/S1329-9360(16)30325-X",
language = "English",
volume = "1",
pages = "12--17",
journal = "Healthcare Infection",
issn = "1329-9360",
publisher = "CSIRO Publishing",
number = "8",

}

Needleless Systems for Intravenous Therapy: Implications for Australian Infection Control. / Murphy, Cathryn.

In: Healthcare Infection, Vol. 1, No. 8, 1995, p. 12-17.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Needleless Systems for Intravenous Therapy: Implications for Australian Infection Control

AU - Murphy, Cathryn

PY - 1995

Y1 - 1995

N2 - Infection Control Practitioners (ICP) are often responsible for recommending the piloting or introduction of new devices in clinical settings. The obligation of employers to provide staff and patients with equipment which minimises their risk of acquiring either occupational or nosocomial infection has lead to an increase in the number of safety devices available. Infection Control practitioners must be prudent in their judgement of both the merits and potential complications of introducing new equipment. This paper reviews existing literature on needleless devices and illustrates the need for ICP to be competent in assessing and undertaking research on new devices and the issues to be considered by ICP in their product evaluation.

AB - Infection Control Practitioners (ICP) are often responsible for recommending the piloting or introduction of new devices in clinical settings. The obligation of employers to provide staff and patients with equipment which minimises their risk of acquiring either occupational or nosocomial infection has lead to an increase in the number of safety devices available. Infection Control practitioners must be prudent in their judgement of both the merits and potential complications of introducing new equipment. This paper reviews existing literature on needleless devices and illustrates the need for ICP to be competent in assessing and undertaking research on new devices and the issues to be considered by ICP in their product evaluation.

U2 - 10.1016/S1329-9360(16)30325-X

DO - 10.1016/S1329-9360(16)30325-X

M3 - Article

VL - 1

SP - 12

EP - 17

JO - Healthcare Infection

JF - Healthcare Infection

SN - 1329-9360

IS - 8

ER -